LCTX vs POOL · rev $9.5M vs P/E 18, rev $5.31B
Lineage Cell Therapeutics Inc (LCTX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
LCTX currently screens at market cap $213.6M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the LCTX and POOL stock pages for the full models.
Not investment advice.